医薬品グリセリン市場:用途別(賦形剤、ケア製品としてのグリセリン)。世界の機会分析および産業予測、2020-2030年Pharmaceutical Glycerine Market By Application (Excipient, Glycerin As Care Product): Global Opportunity Analysis and Industry Forecast, 2020-2030 医薬品グリセリンの世界市場は、2020年に8,989万ドルで、2021年から2030年までCAGR11.0%を記録し、2030年には2億4,648万ドルに達すると予測されています。 世界の医薬品グリセリン市場の総量は、2020年に132,000... もっと見る
サマリー医薬品グリセリンの世界市場は、2020年に8,989万ドルで、2021年から2030年までCAGR11.0%を記録し、2030年には2億4,648万ドルに達すると予測されています。世界の医薬品グリセリン市場の総量は、2020年に132,000トンでしたが、2030年には243,641トンに達すると予測され、2021年から2030年までのCAGRは6.6%を記録しています。 グリセロールは無色のシロップ状の液体で、医療用には下剤として、浣腸として経口投与したり、坐薬の形で使用されます。グリセリンは、食品、化学、製薬、バイオテクノロジー産業において、甘味料、保湿剤、溶剤、微生物培養の餌料として、さまざまな用途に使用されています。 医薬品用グリセリン市場は、抗菌性および抗ウイルス性の特性により、著しい成長を遂げています。グリセリンは、滑らかさを向上させ、潤滑性を与え、皮膚損傷を治療する手段として、医薬品製剤に広く使用されています。また、アレルゲン免疫療法、咳止めシロップ、エリキシル剤、去痰剤、グリセリン石鹸、水性パーソナル潤滑剤などにも使用されています。ニトログリセリンは、慢性狭心症、胸痛、心臓病の治療のための最も一般的な治療法の1つです。グリセリンの医薬品は、ヘルスケア産業において、乾燥肌、肌荒れ、鱗状肌、かゆみ、軽度の肌荒れの治療や予防に保湿剤として使用されています。製薬業界におけるグリセリンの需要の伸び。グリセリンは、スキンケア、ヘアケア、オーラルケア、化粧品などの分野で、保湿剤およびエモリエント剤として使用され、身体の質感の向上、ケラチノサイトの増殖の誘導、傷の治癒、メラニン濃度の低減などに役立てられています。さらに、スキンケアやビューティー&パーソナルケア業界の成長、人口の高齢化、自意識の高まりも、市場成長に寄与すると予想される追加要因の1つです。これとは別に、パーソナルケアおよび化粧品業界におけるグリセリンの高い需要も、予測期間中に市場の成長を加速させると推測されます。グリセリンは、手指消毒剤や口腔ケア製品に広く使用されています。COVID-19の流行により、手指消毒剤の需要が急増し、手指消毒剤メーカーがグリセリンを大量に調達する必要性が高まりました。一方、世界保健機関(WHO)の統計によると、35億人が罹患しているとされる口腔疾患の増加も、市場の成長を促進すると予想されています。 天然素材のパーソナルケア製品や化粧品に対する消費者の志向の高まりは、今後数年間でグリセリン市場の成長を促進するように設定されています。これは主に、化学成分の有害な影響に関する大衆の間で増加する意識プログラムのおかげで発生します。 このレポートでは、医薬品グリセリン市場は、アプリケーションと地域に基づいて検討されています。アプリケーションに基づいて、市場は賦形剤とケア製品としてのグリセリンとして分割されます。賦形剤はさらに、充填剤・可塑剤、可溶化剤・乳化剤、溶剤、希釈剤・基剤、潤滑剤、増粘剤、甘味料に分けられます。地域別では、北米、欧州、アジア太平洋、LAMEAに分かれて分析されています。 地域別では、2020年にアジア太平洋地域が市場を支配し、予測期間中もその地位を維持すると予想されています。これは、マレーシア、インドネシア、インド、日本などのグリセリン生産上位国の高い存在感が、この地域の生産技術や生産能力確保の面で競争環境をもたらしているためです。また、中国、インド、東南アジアの最終用途産業が順調に成長していることから、この地域は当面の間、最速の成長を記録すると予想されています。 世界の医薬品グリセリン市場で事業を展開している主な企業は、Archer Daniels Midland Company、Cargill Inc、DuPont de Nemours, Inc、Emery Oleo chemicals Group、Godrej Group、Procter and Gamble Co.、試薬、再生可能エネルギーグループ株式会社、The Chemical Company、Universal Preserv-A-Chem, Inc.などです。これらのプレイヤーは、製品の発売、コラボレーション、M&Aを主要な開発戦略として採用しています。 ステークホルダーにとっての主なメリット 本レポートは、差し迫った投資ポケットを解明するために、現在のトレンドと将来の予測とともに、世界の医薬品グリセリン市場規模に関する詳細な分析を提供します。 2021年から2030年までの市場分析を提供しており、利害関係者が市場の優勢な機会を活用することを可能にすると期待されます。 地域に関する包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。 主要企業のプロファイルと成長戦略は、世界の医薬品グリセリン市場成長の競争的展望を理解するために徹底的に分析されています。 [S1】amr rdから更新し、それを最終的に考慮してください。 目次CHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION 4.1 Overview 4.1.1 Market size and forecast 4.2 Excipient 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Glycerin As Care Product 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: PHARMACEUTICAL GLYCERINE MARKET, BY REGION 5.1 Overview 5.1.1 Market size and forecast 5.2 North America 5.2.1 Key trends and opportunities 5.2.2 North America Market size and forecast, by Application 5.2.3 North America Market size and forecast, by country 5.2.3.1 U.S. 5.2.3.1.1 Market size and forecast, by Application 5.2.3.2 Canada 5.2.3.2.1 Market size and forecast, by Application 5.2.3.3 Mexico 5.2.3.3.1 Market size and forecast, by Application 5.3 Europe 5.3.1 Key trends and opportunities 5.3.2 Europe Market size and forecast, by Application 5.3.3 Europe Market size and forecast, by country 5.3.3.1 Germany 5.3.3.1.1 Market size and forecast, by Application 5.3.3.2 France 5.3.3.2.1 Market size and forecast, by Application 5.3.3.3 United Kingdom 5.3.3.3.1 Market size and forecast, by Application 5.3.3.4 Italy 5.3.3.4.1 Market size and forecast, by Application 5.3.3.5 Spain 5.3.3.5.1 Market size and forecast, by Application 5.3.3.6 Rest of Europe 5.3.3.6.1 Market size and forecast, by Application 5.4 Asia-Pacific 5.4.1 Key trends and opportunities 5.4.2 Asia-Pacific Market size and forecast, by Application 5.4.3 Asia-Pacific Market size and forecast, by country 5.4.3.1 Japan 5.4.3.1.1 Market size and forecast, by Application 5.4.3.2 China 5.4.3.2.1 Market size and forecast, by Application 5.4.3.3 Australia 5.4.3.3.1 Market size and forecast, by Application 5.4.3.4 India 5.4.3.4.1 Market size and forecast, by Application 5.4.3.5 South Korea 5.4.3.5.1 Market size and forecast, by Application 5.4.3.6 Rest of Asia-Pacific 5.4.3.6.1 Market size and forecast, by Application 5.5 LAMEA 5.5.1 Key trends and opportunities 5.5.2 LAMEA Market size and forecast, by Application 5.5.3 LAMEA Market size and forecast, by country 5.5.3.1 Brazil 5.5.3.1.1 Market size and forecast, by Application 5.5.3.2 Saudi Arabia 5.5.3.2.1 Market size and forecast, by Application 5.5.3.3 South Africa 5.5.3.3.1 Market size and forecast, by Application 5.5.3.4 Rest of LAMEA 5.5.3.4.1 Market size and forecast, by Application CHAPTER 6: COMPANY LANDSCAPE 6.1. Introduction 6.2. Top winning strategies 6.3. Product Mapping of Top 10 Player 6.4. Competitive Dashboard 6.5. Competitive Heatmap 6.6. Key developments CHAPTER 7: COMPANY PROFILES 7.1 DuPont 7.1.1 Company overview 7.1.2 Company snapshot 7.1.3 Operating business segments 7.1.4 Product portfolio 7.1.5 Business performance 7.1.6 Key strategic moves and developments 7.2 cargill 7.2.1 Company overview 7.2.2 Company snapshot 7.2.3 Operating business segments 7.2.4 Product portfolio 7.2.5 Business performance 7.2.6 Key strategic moves and developments 7.3 Universal Preserv A Chem Inc. 7.3.1 Company overview 7.3.2 Company snapshot 7.3.3 Operating business segments 7.3.4 Product portfolio 7.3.5 Business performance 7.3.6 Key strategic moves and developments 7.4 TCC Glycerin 7.4.1 Company overview 7.4.2 Company snapshot 7.4.3 Operating business segments 7.4.4 Product portfolio 7.4.5 Business performance 7.4.6 Key strategic moves and developments 7.5 Procter and Gamble Co 7.5.1 Company overview 7.5.2 Company snapshot 7.5.3 Operating business segments 7.5.4 Product portfolio 7.5.5 Business performance 7.5.6 Key strategic moves and developments 7.6 Godrej Group 7.6.1 Company overview 7.6.2 Company snapshot 7.6.3 Operating business segments 7.6.4 Product portfolio 7.6.5 Business performance 7.6.6 Key strategic moves and developments 7.7 Emery Oleochemicals Group 7.7.1 Company overview 7.7.2 Company snapshot 7.7.3 Operating business segments 7.7.4 Product portfolio 7.7.5 Business performance 7.7.6 Key strategic moves and developments 7.8 Archer Daniels Midland Company 7.8.1 Company overview 7.8.2 Company snapshot 7.8.3 Operating business segments 7.8.4 Product portfolio 7.8.5 Business performance 7.8.6 Key strategic moves and developments 7.9 Renewable Energy Group, Inc. 7.9.1 Company overview 7.9.2 Company snapshot 7.9.3 Operating business segments 7.9.4 Product portfolio 7.9.5 Business performance 7.9.6 Key strategic moves and developments 7.10 Reagents Company 7.10.1 Company overview 7.10.2 Company snapshot 7.10.3 Operating business segments 7.10.4 Product portfolio 7.10.5 Business performance 7.10.6 Key strategic moves and developments LIST OF TABLES TABLE 1. GLOBAL PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 2. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR EXCIPIENT, BY REGION , 2020-2030,($MILLION) TABLE 3. PHARMACEUTICAL GLYCERINE MARKET EXCIPIENT BY COUNTRY, 2020-2030,($MILLION) TABLE 4. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR GLYCERIN AS CARE PRODUCT, BY REGION , 2020-2030,($MILLION) TABLE 5. PHARMACEUTICAL GLYCERINE MARKET GLYCERIN AS CARE PRODUCT BY COUNTRY, 2020-2030,($MILLION) TABLE 6. PHARMACEUTICAL GLYCERINE MARKET, BY REGION, 2020-2030,($MILLION) TABLE 7. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 8. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 9. U.S. PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 10. CANADA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 11. MEXICO PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 12. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 13. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 14. GERMANY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 15. FRANCE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 16. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 17. ITALY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 18. SPAIN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 19. REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 20. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 21. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 22. JAPAN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 23. CHINA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 24. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 25. INDIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 26. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 27. REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 28. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 29. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 30. BRAZIL PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 31. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 32. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 33. REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 34.DUPONT: COMPANY SNAPSHOT TABLE 35.DUPONT: OPERATING SEGMENTS TABLE 36.DUPONT: PRODUCT PORTFOLIO TABLE 37.DUPONT: NET SALES, TABLE 38.DUPONT: KEY STRATERGIES TABLE 39.CARGILL: COMPANY SNAPSHOT TABLE 40.CARGILL: OPERATING SEGMENTS TABLE 41.CARGILL: PRODUCT PORTFOLIO TABLE 42.CARGILL: NET SALES, TABLE 43.CARGILL: KEY STRATERGIES TABLE 44.UNIVERSAL PRESERV A CHEM INC.: COMPANY SNAPSHOT TABLE 45.UNIVERSAL PRESERV A CHEM INC.: OPERATING SEGMENTS TABLE 46.UNIVERSAL PRESERV A CHEM INC.: PRODUCT PORTFOLIO TABLE 47.UNIVERSAL PRESERV A CHEM INC.: NET SALES, TABLE 48.UNIVERSAL PRESERV A CHEM INC.: KEY STRATERGIES TABLE 49.TCC GLYCERIN: COMPANY SNAPSHOT TABLE 50.TCC GLYCERIN: OPERATING SEGMENTS TABLE 51.TCC GLYCERIN: PRODUCT PORTFOLIO TABLE 52.TCC GLYCERIN: NET SALES, TABLE 53.TCC GLYCERIN: KEY STRATERGIES TABLE 54.PROCTER AND GAMBLE CO: COMPANY SNAPSHOT TABLE 55.PROCTER AND GAMBLE CO: OPERATING SEGMENTS TABLE 56.PROCTER AND GAMBLE CO: PRODUCT PORTFOLIO TABLE 57.PROCTER AND GAMBLE CO: NET SALES, TABLE 58.PROCTER AND GAMBLE CO: KEY STRATERGIES TABLE 59.GODREJ GROUP: COMPANY SNAPSHOT TABLE 60.GODREJ GROUP: OPERATING SEGMENTS TABLE 61.GODREJ GROUP: PRODUCT PORTFOLIO TABLE 62.GODREJ GROUP: NET SALES, TABLE 63.GODREJ GROUP: KEY STRATERGIES TABLE 64.EMERY OLEOCHEMICALS GROUP: COMPANY SNAPSHOT TABLE 65.EMERY OLEOCHEMICALS GROUP: OPERATING SEGMENTS TABLE 66.EMERY OLEOCHEMICALS GROUP: PRODUCT PORTFOLIO TABLE 67.EMERY OLEOCHEMICALS GROUP: NET SALES, TABLE 68.EMERY OLEOCHEMICALS GROUP: KEY STRATERGIES TABLE 69.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT TABLE 70.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS TABLE 71.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO TABLE 72.ARCHER DANIELS MIDLAND COMPANY: NET SALES, TABLE 73.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES TABLE 74.RENEWABLE ENERGY GROUP, INC.: COMPANY SNAPSHOT TABLE 75.RENEWABLE ENERGY GROUP, INC.: OPERATING SEGMENTS TABLE 76.RENEWABLE ENERGY GROUP, INC.: PRODUCT PORTFOLIO TABLE 77.RENEWABLE ENERGY GROUP, INC.: NET SALES, TABLE 78.RENEWABLE ENERGY GROUP, INC.: KEY STRATERGIES TABLE 79.REAGENTS COMPANY: COMPANY SNAPSHOT TABLE 80.REAGENTS COMPANY: OPERATING SEGMENTS TABLE 81.REAGENTS COMPANY: PRODUCT PORTFOLIO TABLE 82.REAGENTS COMPANY: NET SALES, TABLE 83.REAGENTS COMPANY: KEY STRATERGIES LIST OF FIGURES FIGURE 1.PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION FIGURE 2.PHARMACEUTICAL GLYCERINE MARKET,2020-2030 FIGURE 3.PHARMACEUTICAL GLYCERINE MARKET,2020-2030 FIGURE 4. TOP INVESTMENT POCKETS, BY REGION FIGURE 5.PORTER FIVE-1 FIGURE 6.PORTER FIVE-2 FIGURE 7.PORTER FIVE-3 FIGURE 8.PORTER FIVE-4 FIGURE 9.PORTER FIVE-5 FIGURE 10.TOP PLAYER POSITIONING FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET,BY APPLICATION,2020(%) FIGURE 12.COMPARATIVE SHARE ANALYSIS OF EXCIPIENT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%) FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GLYCERIN AS CARE PRODUCT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%) FIGURE 14.PHARMACEUTICAL GLYCERINE MARKET BY REGION,2020 FIGURE 15.U.S. PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 16.CANADA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 17.MEXICO PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 18.GERMANY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 19.FRANCE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 20.UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 21.ITALY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 22.SPAIN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 23.REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 24.JAPAN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 25.CHINA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 26.AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 27.INDIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 28.SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 29.REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 30.BRAZIL PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 31.SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 32.SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 33.REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 34. TOP WINNING STRATEGIES, BY YEAR FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS FIGURE 38.COMPETITIVE DASHBOARD FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS FIGURE 40.DUPONT.: NET SALES ,($MILLION) FIGURE 41.CARGILL.: NET SALES ,($MILLION) FIGURE 42.UNIVERSAL PRESERV A CHEM INC..: NET SALES ,($MILLION) FIGURE 43.TCC GLYCERIN.: NET SALES ,($MILLION) FIGURE 44.PROCTER AND GAMBLE CO.: NET SALES ,($MILLION) FIGURE 45.GODREJ GROUP.: NET SALES ,($MILLION) FIGURE 46.EMERY OLEOCHEMICALS GROUP.: NET SALES ,($MILLION) FIGURE 47.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION) FIGURE 48.RENEWABLE ENERGY GROUP, INC..: NET SALES ,($MILLION) FIGURE 49.REAGENTS COMPANY.: NET SALES ,($MILLION)
SummaryThe global pharmaceutical glycerin market was valued at $89.89 million in 2020, and is projected to reach $246.48 million by 2030, registering a CAGR of 11.0% from 2021 to 2030. Table of ContentsCHAPTER 1:INTRODUCTION1.1.Report description 1.2.Key market segments 1.3.Key benefits to the stakeholders 1.4.Research Methodology 1.4.1.Secondary research 1.4.2.Primary research 1.4.3.Analyst tools and models CHAPTER 2:EXECUTIVE SUMMARY 2.1.Key findings of the study 2.2.CXO Perspective CHAPTER 3:MARKET OVERVIEW 3.1.Market definition and scope 3.2.Key findings 3.2.1.Top investment pockets 3.3.Porter’s five forces analysis 3.4.Top player positioning 3.5.Market dynamics 3.5.1.Drivers 3.5.2.Restraints 3.5.3.Opportunities 3.6.COVID-19 Impact Analysis on the market CHAPTER 4: PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION 4.1 Overview 4.1.1 Market size and forecast 4.2 Excipient 4.2.1 Key market trends, growth factors and opportunities 4.2.2 Market size and forecast, by region 4.2.3 Market analysis by country 4.3 Glycerin As Care Product 4.3.1 Key market trends, growth factors and opportunities 4.3.2 Market size and forecast, by region 4.3.3 Market analysis by country CHAPTER 5: PHARMACEUTICAL GLYCERINE MARKET, BY REGION 5.1 Overview 5.1.1 Market size and forecast 5.2 North America 5.2.1 Key trends and opportunities 5.2.2 North America Market size and forecast, by Application 5.2.3 North America Market size and forecast, by country 5.2.3.1 U.S. 5.2.3.1.1 Market size and forecast, by Application 5.2.3.2 Canada 5.2.3.2.1 Market size and forecast, by Application 5.2.3.3 Mexico 5.2.3.3.1 Market size and forecast, by Application 5.3 Europe 5.3.1 Key trends and opportunities 5.3.2 Europe Market size and forecast, by Application 5.3.3 Europe Market size and forecast, by country 5.3.3.1 Germany 5.3.3.1.1 Market size and forecast, by Application 5.3.3.2 France 5.3.3.2.1 Market size and forecast, by Application 5.3.3.3 United Kingdom 5.3.3.3.1 Market size and forecast, by Application 5.3.3.4 Italy 5.3.3.4.1 Market size and forecast, by Application 5.3.3.5 Spain 5.3.3.5.1 Market size and forecast, by Application 5.3.3.6 Rest of Europe 5.3.3.6.1 Market size and forecast, by Application 5.4 Asia-Pacific 5.4.1 Key trends and opportunities 5.4.2 Asia-Pacific Market size and forecast, by Application 5.4.3 Asia-Pacific Market size and forecast, by country 5.4.3.1 Japan 5.4.3.1.1 Market size and forecast, by Application 5.4.3.2 China 5.4.3.2.1 Market size and forecast, by Application 5.4.3.3 Australia 5.4.3.3.1 Market size and forecast, by Application 5.4.3.4 India 5.4.3.4.1 Market size and forecast, by Application 5.4.3.5 South Korea 5.4.3.5.1 Market size and forecast, by Application 5.4.3.6 Rest of Asia-Pacific 5.4.3.6.1 Market size and forecast, by Application 5.5 LAMEA 5.5.1 Key trends and opportunities 5.5.2 LAMEA Market size and forecast, by Application 5.5.3 LAMEA Market size and forecast, by country 5.5.3.1 Brazil 5.5.3.1.1 Market size and forecast, by Application 5.5.3.2 Saudi Arabia 5.5.3.2.1 Market size and forecast, by Application 5.5.3.3 South Africa 5.5.3.3.1 Market size and forecast, by Application 5.5.3.4 Rest of LAMEA 5.5.3.4.1 Market size and forecast, by Application CHAPTER 6: COMPANY LANDSCAPE 6.1. Introduction 6.2. Top winning strategies 6.3. Product Mapping of Top 10 Player 6.4. Competitive Dashboard 6.5. Competitive Heatmap 6.6. Key developments CHAPTER 7: COMPANY PROFILES 7.1 DuPont 7.1.1 Company overview 7.1.2 Company snapshot 7.1.3 Operating business segments 7.1.4 Product portfolio 7.1.5 Business performance 7.1.6 Key strategic moves and developments 7.2 cargill 7.2.1 Company overview 7.2.2 Company snapshot 7.2.3 Operating business segments 7.2.4 Product portfolio 7.2.5 Business performance 7.2.6 Key strategic moves and developments 7.3 Universal Preserv A Chem Inc. 7.3.1 Company overview 7.3.2 Company snapshot 7.3.3 Operating business segments 7.3.4 Product portfolio 7.3.5 Business performance 7.3.6 Key strategic moves and developments 7.4 TCC Glycerin 7.4.1 Company overview 7.4.2 Company snapshot 7.4.3 Operating business segments 7.4.4 Product portfolio 7.4.5 Business performance 7.4.6 Key strategic moves and developments 7.5 Procter and Gamble Co 7.5.1 Company overview 7.5.2 Company snapshot 7.5.3 Operating business segments 7.5.4 Product portfolio 7.5.5 Business performance 7.5.6 Key strategic moves and developments 7.6 Godrej Group 7.6.1 Company overview 7.6.2 Company snapshot 7.6.3 Operating business segments 7.6.4 Product portfolio 7.6.5 Business performance 7.6.6 Key strategic moves and developments 7.7 Emery Oleochemicals Group 7.7.1 Company overview 7.7.2 Company snapshot 7.7.3 Operating business segments 7.7.4 Product portfolio 7.7.5 Business performance 7.7.6 Key strategic moves and developments 7.8 Archer Daniels Midland Company 7.8.1 Company overview 7.8.2 Company snapshot 7.8.3 Operating business segments 7.8.4 Product portfolio 7.8.5 Business performance 7.8.6 Key strategic moves and developments 7.9 Renewable Energy Group, Inc. 7.9.1 Company overview 7.9.2 Company snapshot 7.9.3 Operating business segments 7.9.4 Product portfolio 7.9.5 Business performance 7.9.6 Key strategic moves and developments 7.10 Reagents Company 7.10.1 Company overview 7.10.2 Company snapshot 7.10.3 Operating business segments 7.10.4 Product portfolio 7.10.5 Business performance 7.10.6 Key strategic moves and developments LIST OF TABLES TABLE 1. GLOBAL PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 2. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR EXCIPIENT, BY REGION , 2020-2030,($MILLION) TABLE 3. PHARMACEUTICAL GLYCERINE MARKET EXCIPIENT BY COUNTRY, 2020-2030,($MILLION) TABLE 4. PHARMACEUTICAL GLYCERINE MARKET REVENUE, FOR GLYCERIN AS CARE PRODUCT, BY REGION , 2020-2030,($MILLION) TABLE 5. PHARMACEUTICAL GLYCERINE MARKET GLYCERIN AS CARE PRODUCT BY COUNTRY, 2020-2030,($MILLION) TABLE 6. PHARMACEUTICAL GLYCERINE MARKET, BY REGION, 2020-2030,($MILLION) TABLE 7. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 8. NORTH AMERICA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 9. U.S. PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 10. CANADA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 11. MEXICO PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 12. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 13. EUROPE PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 14. GERMANY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 15. FRANCE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 16. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 17. ITALY PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 18. SPAIN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 19. REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 20. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 21. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 22. JAPAN PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 23. CHINA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 24. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 25. INDIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 26. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 27. REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 28. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY APPLICATION, 2020-2030,($MILLION) TABLE 29. LAMEA PHARMACEUTICAL GLYCERINE MARKET, BY COUNTRY, 2020-2030,($MILLION) TABLE 30. BRAZIL PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 31. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 32. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 33. REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET BY APPLICATION 2020-2030,($MILLION) TABLE 34.DUPONT: COMPANY SNAPSHOT TABLE 35.DUPONT: OPERATING SEGMENTS TABLE 36.DUPONT: PRODUCT PORTFOLIO TABLE 37.DUPONT: NET SALES, TABLE 38.DUPONT: KEY STRATERGIES TABLE 39.CARGILL: COMPANY SNAPSHOT TABLE 40.CARGILL: OPERATING SEGMENTS TABLE 41.CARGILL: PRODUCT PORTFOLIO TABLE 42.CARGILL: NET SALES, TABLE 43.CARGILL: KEY STRATERGIES TABLE 44.UNIVERSAL PRESERV A CHEM INC.: COMPANY SNAPSHOT TABLE 45.UNIVERSAL PRESERV A CHEM INC.: OPERATING SEGMENTS TABLE 46.UNIVERSAL PRESERV A CHEM INC.: PRODUCT PORTFOLIO TABLE 47.UNIVERSAL PRESERV A CHEM INC.: NET SALES, TABLE 48.UNIVERSAL PRESERV A CHEM INC.: KEY STRATERGIES TABLE 49.TCC GLYCERIN: COMPANY SNAPSHOT TABLE 50.TCC GLYCERIN: OPERATING SEGMENTS TABLE 51.TCC GLYCERIN: PRODUCT PORTFOLIO TABLE 52.TCC GLYCERIN: NET SALES, TABLE 53.TCC GLYCERIN: KEY STRATERGIES TABLE 54.PROCTER AND GAMBLE CO: COMPANY SNAPSHOT TABLE 55.PROCTER AND GAMBLE CO: OPERATING SEGMENTS TABLE 56.PROCTER AND GAMBLE CO: PRODUCT PORTFOLIO TABLE 57.PROCTER AND GAMBLE CO: NET SALES, TABLE 58.PROCTER AND GAMBLE CO: KEY STRATERGIES TABLE 59.GODREJ GROUP: COMPANY SNAPSHOT TABLE 60.GODREJ GROUP: OPERATING SEGMENTS TABLE 61.GODREJ GROUP: PRODUCT PORTFOLIO TABLE 62.GODREJ GROUP: NET SALES, TABLE 63.GODREJ GROUP: KEY STRATERGIES TABLE 64.EMERY OLEOCHEMICALS GROUP: COMPANY SNAPSHOT TABLE 65.EMERY OLEOCHEMICALS GROUP: OPERATING SEGMENTS TABLE 66.EMERY OLEOCHEMICALS GROUP: PRODUCT PORTFOLIO TABLE 67.EMERY OLEOCHEMICALS GROUP: NET SALES, TABLE 68.EMERY OLEOCHEMICALS GROUP: KEY STRATERGIES TABLE 69.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT TABLE 70.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS TABLE 71.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO TABLE 72.ARCHER DANIELS MIDLAND COMPANY: NET SALES, TABLE 73.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES TABLE 74.RENEWABLE ENERGY GROUP, INC.: COMPANY SNAPSHOT TABLE 75.RENEWABLE ENERGY GROUP, INC.: OPERATING SEGMENTS TABLE 76.RENEWABLE ENERGY GROUP, INC.: PRODUCT PORTFOLIO TABLE 77.RENEWABLE ENERGY GROUP, INC.: NET SALES, TABLE 78.RENEWABLE ENERGY GROUP, INC.: KEY STRATERGIES TABLE 79.REAGENTS COMPANY: COMPANY SNAPSHOT TABLE 80.REAGENTS COMPANY: OPERATING SEGMENTS TABLE 81.REAGENTS COMPANY: PRODUCT PORTFOLIO TABLE 82.REAGENTS COMPANY: NET SALES, TABLE 83.REAGENTS COMPANY: KEY STRATERGIES LIST OF FIGURES FIGURE 1.PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION FIGURE 2.PHARMACEUTICAL GLYCERINE MARKET,2020-2030 FIGURE 3.PHARMACEUTICAL GLYCERINE MARKET,2020-2030 FIGURE 4. TOP INVESTMENT POCKETS, BY REGION FIGURE 5.PORTER FIVE-1 FIGURE 6.PORTER FIVE-2 FIGURE 7.PORTER FIVE-3 FIGURE 8.PORTER FIVE-4 FIGURE 9.PORTER FIVE-5 FIGURE 10.TOP PLAYER POSITIONING FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES FIGURE 11.PHARMACEUTICAL GLYCERINE MARKET,BY APPLICATION,2020(%) FIGURE 12.COMPARATIVE SHARE ANALYSIS OF EXCIPIENT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%) FIGURE 13.COMPARATIVE SHARE ANALYSIS OF GLYCERIN AS CARE PRODUCT PHARMACEUTICAL GLYCERINE MARKET,2020-2030(%) FIGURE 14.PHARMACEUTICAL GLYCERINE MARKET BY REGION,2020 FIGURE 15.U.S. PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 16.CANADA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 17.MEXICO PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 18.GERMANY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 19.FRANCE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 20.UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 21.ITALY PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 22.SPAIN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 23.REST OF EUROPE PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 24.JAPAN PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 25.CHINA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 26.AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 27.INDIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 28.SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 29.REST OF ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 30.BRAZIL PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 31.SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 32.SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 33.REST OF LAMEA PHARMACEUTICAL GLYCERINE MARKET,2020-2030($MILLION) FIGURE 34. TOP WINNING STRATEGIES, BY YEAR FIGURE 35. TOP WINNING STRATEGIES, BY DEVELOPMENT FIGURE 36. TOP WINNING STRATEGIES, BY COMPANY FIGURE 37.PRODUCT MAPPING OF TOP 10 PLAYERS FIGURE 38.COMPETITIVE DASHBOARD FIGURE 39.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS FIGURE 40.DUPONT.: NET SALES ,($MILLION) FIGURE 41.CARGILL.: NET SALES ,($MILLION) FIGURE 42.UNIVERSAL PRESERV A CHEM INC..: NET SALES ,($MILLION) FIGURE 43.TCC GLYCERIN.: NET SALES ,($MILLION) FIGURE 44.PROCTER AND GAMBLE CO.: NET SALES ,($MILLION) FIGURE 45.GODREJ GROUP.: NET SALES ,($MILLION) FIGURE 46.EMERY OLEOCHEMICALS GROUP.: NET SALES ,($MILLION) FIGURE 47.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION) FIGURE 48.RENEWABLE ENERGY GROUP, INC..: NET SALES ,($MILLION) FIGURE 49.REAGENTS COMPANY.: NET SALES ,($MILLION)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ネットワーク)の最新刊レポート
Allied Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(as)の最新刊レポート
よくあるご質問Allied Market Research社はどのような調査会社ですか?アライドマーケットリサーチ(Allied Market Research)は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |